Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma
Mitsubishi Chemical (TYO:4188) has denied recent reports by Nikkei suggesting it is negotiating the sale of Mitsubishi Tanabe Pharma Corporation, according to a Monday filing on the Tokyo Stock Exchange.
The company clarified that it has not announced any such sale and emphasized that no such transaction is currently underway.
Mitsubishi Chemical is actively reviewing its business portfolio, including its pharmaceutical segment, and is considering various strategic options, including divestitures.
Price (JPY): $911.60, Change: $+11, Percent Change: +1.17%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.